FindMyKOL

Christine McCrary, MD

Basic profile

Hartford Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionHartford, CT · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2023FindMyKOL type: RegionalLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Christine McCrary is a Rheumatology/Immunology physician affiliated with Hartford Hospital. OpenAlex indexes 8 publications with 508 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8publications

Publications indexed by OpenAlex. Counts exclude supporting files.

508citations

Citations across these publications.

4h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Aurinia Pharma U.S., Inc.
    Program year20232 payments
    $47
  • Amgen Inc.
    Program year20232 payments
    $43
  • PFIZER INC.
    Program year20231 payment
    $22
All 10 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    25.1%
    Corticosteroid21.5%
    Prednisone100%
    Part D≥136 patients
    Antidiarrheal microorganisms2.2%
    Folic Acid100%
    Part D≥15 patients

    + 2 more classes in this area

  • Nervous system

    23.8%
    Opioid Agonist6.7%
    Tramadol Hcl86%Oxycodone-Acetaminophen14%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug6.6%
    Meloxicam88%Ibuprofen13%
    Part D<11 patients

    + 4 more classes in this area

  • Cancer & immunology

    23.2%
    Folate Analog Metabolic Inhibitor10.7%
    Methotrexate100%
    Part D≥82 patients
    Nonsteroidal Anti-inflammatory Drug3.8%
    Celecoxib100%
    Part D≥27 patients

    + 7 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”